Figure legends

Figure 1: Study design. Patients of the intervention group befenited from a pharmaceutical intervention the day of the inclusion (D0; day 0). Both groups had a follow-up consultation three months (M3) after the inclusion, and control group benefited from a pharmaceutical intervention after the follow-up consultation.
Figure 2: Number of inclusion and lost to follow-up